Avoro Capital Advisors LLC Sarepta Therapeutics, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
A detailed history of Avoro Capital Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,674,835 shares of SRPT stock, worth $36.4 Million. This represents 2.76% of its overall portfolio holdings.
Number of Shares
2,674,835
Previous 2,555,555
4.67%
Holding current value
$36.4 Million
Previous $311 Million
45.06%
% of portfolio
2.76%
Previous 4.53%
Shares
24 transactions
Others Institutions Holding SRPT
# of Institutions
500Shares Held
89.2MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$141 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$123 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$123 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$55.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$45.8 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.19B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...